Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation: the ORIGAMI II Study

NCT06285942 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria Maggiore della Carita as lead sponsor.

NCT NCT06285942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06285942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation: the ORIGAMI II Study
Lead sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2024
Completion date
January 31, 2025
Enrollment
168 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, fragility